Modified humanised anti-interleukin-18 antibodies

Details for Australian Patent Application No. 2007267213 (hide)

Owner Glaxo Group Limited

Inventors Kirby, Ian; Germaschewski, Volker; Ellis, Jonathan Henry; Hamblin, Paul Andrew

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2007267213

PCT Pub. Number WO2007/137984

Priority 0610438.4 25.05.06 GB; 0611046.4 05.06.06 GB

Filing date 23 May 2007

Wipo publication date 6 December 2007

Acceptance publication date 29 March 2012

International Classifications

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

C07K 14/54 (2006.01) Peptides having more than 20 amino acids

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

4 December 2008 PCT application entered the National Phase

  PCT publication WO2007/137984 Priority application(s): WO2007/137984

29 March 2012 Application Accepted

  Published as AU-B-2007267213

26 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007267234-Method for regulating an active chassis of a tracked vehicle

2007267209-Nitrated heterocyclic compounds as endothelin receptor antagonist